{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:20Z","timestamp":1771275740748,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-026-10353-2","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:17:41Z","timestamp":1769401061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research status and trends in venous thromboembolism and pancreatic cancer: a bibliometric analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Shengyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"10353_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921","journal-title":"Cancer Res"},{"key":"10353_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395:2008\u20132020","journal-title":"Lancet"},{"key":"10353_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:1\u201322","journal-title":"Nat Rev Dis Primers"},{"key":"10353_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT (2017) Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost 117:219\u2013230","journal-title":"Thromb Haemost"},{"key":"10353_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","volume":"118","author":"A Falanga","year":"2017","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A (2017) Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol 118:79\u201383","journal-title":"Crit Rev Oncol Hematol"},{"key":"10353_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AY, Arcelus JI et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38:496\u2013520","journal-title":"J Clin Oncol"},{"key":"10353_CR7","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","volume":"101","author":"C Chen","year":"2004","unstructured":"Chen C (2004) Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A 101:5303\u20135310","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10353_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.810774","volume":"12","author":"K Wu","year":"2022","unstructured":"Wu K, Liu Y, Liu L, Peng Y, Pang H, Sun X et al (2022) Emerging trends and research foci in tumor microenvironment of pancreatic cancer: a bibliometric and visualized study. Front Oncol 12:810774","journal-title":"Front Oncol"},{"key":"10353_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23770","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yang Y, Wu F (2024) A bibliometric analysis in venous thromboembolism nursing (1999\u20132022): current status and future prospects. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23770","journal-title":"Heliyon"},{"key":"10353_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/foods9020166","volume":"9","author":"X-L Zhang","year":"2020","unstructured":"Zhang X-L, Zheng Y, Xia M-L, Wu Y-N, Liu X-J, Xie S-K et al (2020) Knowledge domain and emerging trends in vinegar research: a bibliometric review of the literature from WoSCC. Foods 9:166","journal-title":"Foods"},{"key":"10353_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5195\/jmla.2022.1434","volume":"110","author":"H Arruda","year":"2022","unstructured":"Arruda H, Silva ER, Lessa M, Proen\u00e7a JD, Bartholo R (2022) VOSviewer and bibliometrix. J Med Libr Assoc 110:392","journal-title":"J Med Libr Assoc"},{"key":"10353_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1108\/LHT-07-2021-0227","volume":"40","author":"A \u015eahin","year":"2022","unstructured":"\u015eahin A, Y\u0131lmaz G (2022) Local food research: a bibliometric review using Citespace II (1970\u20132020). Libr Hi Tech 40:848\u2013870","journal-title":"Libr Hi Tech"},{"key":"10353_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C (2017) bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr 11:959\u2013975","journal-title":"J Informetr"},{"key":"10353_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/jimr.jimr_11_22","volume":"1","author":"M Manjareeka","year":"2023","unstructured":"Manjareeka M (2023) Evaluation of researchers: H-index or G-index which is better? J Integr Med Res 1:34\u201336","journal-title":"J Integr Med Res"},{"key":"10353_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.295.1.90","volume":"295","author":"E Garfield","year":"2006","unstructured":"Garfield E (2006) The history and meaning of the journal impact factor. JAMA 295:90\u201393","journal-title":"JAMA"},{"key":"10353_CR16","doi-asserted-by":"publisher","unstructured":"Key NS, Khorana AA, Mackman N, McCarty OJ, White GC, Francis CW, AACR et al (2016) Thrombosis in cancer: research priorities identified by a national cancer institute\/national heart, lung, and blood institute strategic working group. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3100","DOI":"10.1158\/0008-5472.CAN-15-3100"},{"key":"10353_CR17","first-page":"2011","volume":"122","author":"I Pabinger","year":"2013","unstructured":"Pabinger I, Thaler J, Ay C (2013) Biomarkers for prediction of venous thromboembolism in cancer. Blood, The Journal of the American Society of Hematology 122:2011\u20132018","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10353_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMoa1711948","volume":"378","author":"GE Raskob","year":"2018","unstructured":"Raskob GE, Van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D et al (2018) Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 378:615\u2013624","journal-title":"N Engl J Med"},{"key":"10353_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1200\/JCO.2016.67.4564","volume":"35","author":"AA Khorana","year":"2017","unstructured":"Khorana AA, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF et al (2017) Tissue factor as a predictor of recurrent venous thromboembolism in malignancy: biomarker analyses of the CATCH trial. J Clin Oncol 35:1078\u20131085","journal-title":"J Clin Oncol"},{"key":"10353_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1160\/TH10-12-0789","volume":"106","author":"LA Menapace","year":"2011","unstructured":"Menapace LA, Peterson DR, Berry A, Sousou T, Khorana AA (2011) Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer. Thromb Haemost 106:371\u2013378","journal-title":"Thromb Haemost"},{"key":"10353_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ejca.2011.10.017","volume":"48","author":"A Maraveyas","year":"2012","unstructured":"Maraveyas A, Waters J, Roy R, Fyfe D, Propper D, Lofts F et al (2012) Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. Eur J Cancer 48:1283\u20131292","journal-title":"Eur J Cancer"},{"key":"10353_CR22","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.2014.55.1481","volume":"33","author":"U Pelzer","year":"2015","unstructured":"Pelzer U, Opitz B, Deutschinoff G, Stauch M, Reitzig PC, Hahnfeld S et al (2015) Efficacy of prophylactic low\u2013molecular weight heparin for ambulatory patients with advanced pancreatic cancer: outcomes from the CONKO-004 trial. J Clin Oncol 33:2028\u20132034","journal-title":"J Clin Oncol"},{"key":"10353_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","volume":"35","author":"J Beyer-Westendorf","year":"2014","unstructured":"Beyer-Westendorf J, Gelbricht V, F\u00f6rster K, Ebertz F, K\u00f6hler C, Werth S et al (2014) Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J 35:1888\u20131896","journal-title":"Eur Heart J"},{"key":"10353_CR24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, Mu\u00f1oz A, Huisman MV, Connors JM et al (2020) Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 382:1599\u20131607","journal-title":"N Engl J Med"},{"key":"10353_CR25","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","volume":"36","author":"AM Young","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C et al (2018) Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol 36:2017\u20132023","journal-title":"J Clin Oncol"},{"key":"10353_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/bjh.12163","volume":"160","author":"JI Zwicker","year":"2013","unstructured":"Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R et al (2013) Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol 160:530\u2013537","journal-title":"Br J Haematol"},{"key":"10353_CR27","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","volume":"119","author":"J-G Wang","year":"2012","unstructured":"Wang J-G, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC et al (2012) Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 119:5543\u20135552","journal-title":"Blood"},{"key":"10353_CR28","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","volume":"10","author":"J Thaler","year":"2012","unstructured":"Thaler J, Ay C, Mackman N, Bertina R, Kaider A, Marosi C et al (2012) Microparticle\u2010associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 10:1363\u20131370","journal-title":"J Thromb Haemost"},{"key":"10353_CR29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","volume":"122","author":"JE Geddings","year":"2013","unstructured":"Geddings JE, Mackman N (2013) Tumor-derived tissue factor\u2013positive microparticles and venous thrombosis in cancer patients. Blood 122:1873\u20131880","journal-title":"Blood"},{"key":"10353_CR30","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1200419109","volume":"109","author":"M Demers","year":"2012","unstructured":"Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA et al (2012) Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A 109:13076\u201313081","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10353_CR31","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20082297","volume":"206","author":"GM Thomas","year":"2009","unstructured":"Thomas GM, Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C (2009) Cancer cell\u2013derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206:1913\u20131927","journal-title":"J Exp Med"},{"key":"10353_CR32","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1111\/jth.13871","volume":"15","author":"K Date","year":"2017","unstructured":"Date K, Ettelaie C, Maraveyas A (2017) Tissue factor\u2010bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer. J Thromb Haemost 15:2289\u20132299","journal-title":"J Thromb Haemost"},{"key":"10353_CR33","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/jth.14824","volume":"18","author":"N van Es","year":"2020","unstructured":"van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M et al (2020) The khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta\u2010analysis. J Thromb Haemost 18:1940\u20131951","journal-title":"J Thromb Haemost"},{"key":"10353_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12253-017-0239-x","volume":"24","author":"N Awkar","year":"2018","unstructured":"Awkar N, Amireh S, Rai S, Shaaban H, Guron G, Maroules M (2018) Association between level of tumor markers and development of VTE in patients with pancreatic, colorectal and ovarian Ca: retrospective case-control study in two community hospitals. Pathol Oncol Res 24:283\u2013287","journal-title":"Pathol Oncol Res"},{"key":"10353_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2017.06.021","volume":"157","author":"S Kruger","year":"2017","unstructured":"Kruger S, Haas M, Burkl C, Goehring P, Kleespies A, Roeder F et al (2017) Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer\u2013a retrospective cohort study. Thromb Res 157:9\u201315","journal-title":"Thromb Res"},{"issue":"3","key":"10353_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0043-1777304","volume":"50","author":"RAL Willems","year":"2024","unstructured":"Willems RAL, Biesmans C, Campello E, Simioni P, de Laat B, de Vos-Geelen J, Roest M, Ten Cate H (2024) Cellular components contributing to the development of venous thrombosis in patients with pancreatic cancer. Semin Thromb Hemost. 50(3):429\u2013442. https:\/\/doi.org\/10.1055\/s-0043-1777304","journal-title":"Semin Thromb Hemost."},{"issue":"1346\u201358","key":"10353_CR37","volume":"158","author":"C Frere","year":"2020","unstructured":"Frere C, Bournet B, Gourgou S, Fraisse J, Canivet C, Connors JM et al (2020) Incidence of venous thromboembolism in patients with newly diagnosed pancreatic cancer and factors associated with outcomes. Gastroenterology 158(1346\u201358):e4","journal-title":"Gastroenterology"},{"key":"10353_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s42506-022-00120-6","volume":"97","author":"M Machaalani","year":"2022","unstructured":"Machaalani M, El Masri J, El Ayoubi LM, Matar B (2022) Cancer research activity in the Arab world: a 15-year bibliometric analysis. J Egypt Public Health Assoc 97:26","journal-title":"J Egypt Public Health Assoc"},{"key":"10353_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00296-021-04852-0","volume":"42","author":"DE Masri","year":"2022","unstructured":"Masri DE, Alsaayed B, Masri JE, Zreika B, Chanbour H, Salameh P (2022) Contribution of Arab countries to familial Mediterranean fever research: a pubmed-based bibliometric analysis. Rheumatol Int 42:95\u2013100","journal-title":"Rheumatol Int"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10353-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:03:49Z","timestamp":1771272229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10353-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10353"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10353-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}